Hyperphenylalaninemia

Hyperphenylalaninemia is a metabolic disorder characterized by elevated levels of the amino acid phenylalanine in the blood. Phenylalanine is a building block of proteins that is obtained through the diet, primarily from protein-containing foods. In individuals with hyperphenylalaninemia, the metabolic process that converts phenylalanine into another amino acid, tyrosine, is impaired, leading to an accumulation of phenylalanine in the body. This condition can result from a variety of genetic and non-genetic causes, with the most severe form being Phenylketonuria (PKU).

Causes

Hyperphenylalaninemia can be caused by mutations in several genes, with the most common being mutations in the PAH gene, which encodes the enzyme phenylalanine hydroxylase. This enzyme is crucial for the normal metabolism of phenylalanine. Deficiencies in this enzyme lead to varying degrees of hyperphenylalaninemia, depending on the specific mutation and its effect on enzyme activity. Other less common causes include deficiencies in the enzymes or cofactors involved in the metabolic pathway downstream of phenylalanine hydroxylase.

Classification

Hyperphenylalaninemia is classified based on the blood phenylalanine levels and the underlying cause. The most severe form is Phenylketonuria (PKU), which is characterized by very high levels of phenylalanine and is caused by a near-total deficiency of phenylalanine hydroxylase activity. Milder forms of hyperphenylalaninemia result from partial deficiencies of this enzyme or from defects in the synthesis or recycling of tetrahydrobiopterin (BH4), a cofactor necessary for the enzyme's activity.

Symptoms

The symptoms of hyperphenylalaninemia vary depending on the severity of the condition. In severe cases, such as untreated PKU, symptoms can include intellectual disability, behavioral problems, seizures, and a musty odor in the breath, skin, or urine due to the accumulation of phenylalanine and its byproducts. Milder forms of the condition may be asymptomatic or may only become apparent under conditions of stress or increased protein intake.

Diagnosis

Diagnosis of hyperphenylalaninemia typically involves newborn screening, which can detect elevated levels of phenylalanine in the blood. Confirmatory tests, including genetic testing and enzyme activity assays, may be performed to determine the specific type and cause of hyperphenylalaninemia.

Treatment

The treatment of hyperphenylalaninemia depends on its cause and severity. Dietary management is the mainstay of treatment for most forms of the condition. This involves a diet low in phenylalanine, which helps to prevent the accumulation of this amino acid and its toxic byproducts. For individuals with PKU, a synthetic form of the enzyme that is deficient or a medication that enhances the residual activity of the enzyme may also be used. In some cases, treatment with sapropterin, a synthetic form of BH4, may be effective, particularly in individuals with hyperphenylalaninemia due to a deficiency in this cofactor.

Prognosis

With early diagnosis and appropriate treatment, individuals with hyperphenylalaninemia can lead healthy lives. However, untreated or poorly managed hyperphenylalaninemia can lead to severe intellectual and developmental disabilities.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian